A␤ 1-42 is a self-associating peptide whose neurotoxic derivatives are thought to play a role in Alzheimer's pathogenesis. Neurotoxicity of amyloid ␤ protein (A␤) has been attributed to its fibrillar forms, but experiments presented here characterize neurotoxins that assemble when fibril formation is inhibited. These neurotoxins comprise small diffusible A␤ oligomers (referred to as ADDLs, for A␤-derived diffusible ligands), which were found to kill mature neurons in organotypic central nervous system cultures at nanomolar concentrations. At cell surfaces, ADDLs bound to trypsin-sensitive sites and surface-derived tryptic peptides blocked binding and afforded neuroprotection. Germ-line knockout of Fyn, a protein tyrosine kinase linked to apoptosis and elevated in Alzheimer's disease, also was neuroprotective. Remarkably, neurological dysfunction evoked by ADDLs occurred well in advance of cellular degeneration. Without lag, and despite retention of evoked action potentials, ADDLs inhibited hippocampal long-term potentiation, indicating an immediate impact on signal transduction. We hypothesize that impaired synaptic plasticity and associated memory dysfunction during early stage Alzheimer's disease and severe cellular degeneration and dementia during end stage could be caused by the biphasic impact of A␤-derived diffusible ligands acting upon particular neural signal transduction pathways.
Progressive dementia in Alzheimer's disease (AD) is associated with selective neuronal degeneration and death (1) . Causes remain uncertain, but the amyloid hypothesis, which states that central nervous system (CNS) build-up of amyloid ␤ peptide (A␤) is neurotoxic, has received increasing support (2) . Neurotoxicity in cell culture (3, 4) depends on A␤ selfassociation (5). Self-association occurs faster for the longer, more hydrophobic forms of A␤ (i.e., A␤ versus A␤ ; see refs. 6 and 7). A␤ is more abundant in AD brain tissue than in age-matched controls (8) , and production of A␤ in cell transfection experiments is increased by APP and presenilin mutations that cause AD (9, 10) . ApoE4 alleles, which increase risk of AD, also increase A␤ accumulation (11) . Recently, transgenic expression of human genes linked to elevated A␤ has produced mice that exhibit certain Alzheimer's-like molecular, cellular, and behavioral phenotypes (12) (13) (14) .
Despite its support, the amyloid hypothesis has been widely challenged (15) . An imperfect correlation exists between amyloid deposits and dementia (16, 17) , and doses of fibrillar A␤ needed to kill neurons in culture appear excessive (18) . An underappreciated possibility is that A␤ may give rise to small toxic derivatives other than the highly aggregated species found in amyloid deposits (19, 20) . Although significant support exists for the idea that toxic forms of A␤ comprise large fibrils (21, 22) , these experiments typically have been carried out with pure A␤ allowed to aggregate out of homogeneous solutions. A␤, however, selectively interacts with various molecules, including proteins found in neuritic plaques (20, (23) (24) (25) (26) (27) (28) .
An appealing hypothesis is that other molecules elevated in AD brain may chaperone A␤ self-association, leading to toxic A␤ oligomers that are diffusible and potentially more pernicious than fibrillar A␤. Support for this hypothesis comes from recent findings that low amounts of clusterin (Apo J), a senile plaque protein, give rise to slowly sedimenting A␤ derivatives with enhanced mitochondrial toxicity in neuronlike PC12 cells (19, 20) . We now have found that these slowly sedimenting neurotoxins comprise soluble, ligand-like A␤ oligomers that are nonfibrillar, readily diffusible, and toxic to mature CNS neurons at nanomolar concentrations. Current data suggest that A␤-derived diffusible ligand (ADDL) toxicity depends on cell surface toxin receptors and Fyn, a nonreceptor protein tyrosine kinase that is overexpressed in AD (29).
SDS͞PAGE was as described (32) . Proteins were visualized by silver stain (33) . For immunoblots, proteins were transferred to nitrocellulose membranes (32) , incubated with biotinylated 6E10 antibody (Senetek, St. Louis, MO) at 1:2,000 and visualized by ECL (Amersham). Molecular mass was estimated with MultiMark standards (Novex).
Mouse Brain Slice Culture and Assay for Viability. Brain slices from strain (B6 ϫ 129)F 2 ͞J and strain JR 2385 (The Jackson Laboratories) were cultured as described (34) , except growth medium was DMEM, 10% fetal calf serum, and antibiotic͞antimycotic (all from Life Technologies), and horizontal slices of 200 m were used. After overnight culture, medium was changed to defined medium (DMEM, N2 supplements antibiotic͞antimycotic) with or without ADDLs. Viability was assessed after 24 hr by Live͞Dead two-color fluorescence assay according to the manufacturer's instructions (Molecular Probes). Slices were washed in Hanks' balanced salt solution (HBSS) and exposed to 4m calcein-AM and 2 M ethidium homodimer in HBSS for 20 min at 37°C. Dye uptake was detected by using a Nikon Diaphot with filter cubes for fluorescein (for calcein in live cells) and Texas red (for ethidium homodimer in dead cells). Image analysis to quantify Live͞Dead fluorescence was performed by using METAMORPH (Universal Imaging, Philadelphia).
Binding of ADDLs to Cell Surfaces. Cell suspensions (2.5 ϫ 10 5 cells͞500 l PBS) were incubated with 5 M ADDLs at 4°C for 1 hr. Cells were pelleted and resuspended in 500 l ice-cold PBS and incubated with biotinylated 6E10 mAb (1 l; Senetek) for 30 min. Cell were washed and then incubated in 500 l PBS with f luorescein isothiocyanate-conjugated streptavidin (1:500; Amersham) for 30 min. Relative binding was quantified by FACScan (Becton Dickinson), multiplying mean fluorescence by total number of events, and subtracting values for background cell fluorescence in the presence of 6E10 and secondary antibody.
Preparation of Tryptic Peptides. Confluent B103 cells (35) were removed by trypsinization (0.25%; Life Technologies) for Ϸ3 min. Trypsin-chymotrypsin inhibitor (Sigma; 0.5 mg͞ml in Hanks' buffered saline) was added, and cells were pelleted via centrifugation (500 ϫ g, 5 min). Supernatant (Ϸ12 ml) was concentrated to Ϸ1.0 ml by using a Centricon 3 filter (Amicon) and frozen after protein concentration was determined. For blocking experiments, sterile concentrated tryptic peptides (0.25 mg͞ml) were added at the same time as ADDLs.
Electrophysiology. Long-term potentiation (LTP) experiments were performed on P21 rat hippocampal slices, as described (36) .
RESULTS
ADDLs: A␤-Derived Neurotoxins That Are Soluble and Fibril-Free. Although the toxic form of A␤ putatively is fibrillar (21, 22) , neurotoxins that do not behave as sedimentable fibrils will form when A␤ 1-42 is incubated with clusterin (20) . When examined by AFM, these preparations were completely fibril-free, exclusively comprising small globular structures (AFM; Fig. 1, Right) . Equivalent results were obtained by conventional electron microscopy (data not shown). In contrast, A␤ 1-42 that self-associated without clusterin under standard conditions (31) showed typical fibrillar structure (Fig. 1,  Left) . The fibril-free A␤ derivatives will be referred to as ADDLs.
As done previously for fibrils (31) , size characterization of ADDLs by AFM section analysis indicated that the predominant species were globules Ϸ4.8-5.7 nm along the z-axis. Comparison with small globular proteins (A␤ 1-40 monomer, aprotinin, basic fibroblast growth factor, carbonic anhydrase) suggested that ADDLs had mass between 17 and 42 kDa.
ADDLs of this mass would be too small to contain clusterin (M r 80,000), indicating a chaperone-like function for clusterin (present at molarity 1:40 relative to A␤). To verify this, however, conditions were sought in which ADDLs could form without clusterin. It was found that ADDLs could form in clusterin-free A␤ solutions if incubation was at reduced temperature (4-8°C). Cold-induced ADDLs were indistinguishable from those chaperoned by clusterin. In addition, ADDLs could form in clusterin-free tissue culture medium held at 37°C if A␤ was very dilute (50 nM), consistent with a potential to form physiologically. Morphologically, all ADDL solutions were stable at least 24 hr.
The fibril-free nature of ADDLs established by AFM was verified by nondenaturing gel electrophoresis. Nondenaturing gels showed ADDLs were oligomeric ( Fig. 1, Inset) , with the predominant species at 27 kDa and a minor species at 17 kDa. Western blot analysis of ADDL preparations resolved by SDS͞PAGE showed similar bands at 22 and 17 kDa (Fig. 1 , lane W). The presence of similar molecular weight A␤ species in nondenaturing and SDS gels indicates the oligomeric nature of ADDLs was not detergent-induced. Silver-stained SDS gels ( Fig. 1, lanes 1-4) showed only the larger, more abundant ADDL oligomer, which was present whether ADDLs were clusterin-or cold-induced (lanes 1 and 2, respectively; lane 1 also shows the 40-kDa clusterin monomer). Monomeric A␤ seen in these SDS gels was not eliminated by prior Centricon 10 fractionation. Centricon retentate (lane 3) was indistinguishable from unfractionated ADDLs (lane 2), despite the ability of monomer to pass through the 10-kDa pore (eluate, lane 4). This result would be expected if the ADDLs were only partially detergent-stable.
Cell Death in Organotypic Mouse Brain Slice Cultures. ADDL toxicity was tested in organotypic mouse brain slice cultures, which provided a physiologically relevant model for mature CNS. Whether induced by clusterin (Fig. 2) , by low temperature, or by low A␤ concentration (data not shown), ADDLs were potent neurotoxins. To obtain high levels of viability in controls (below), cultures were supported by a filter at the medium-atmosphere interface. ADDLs thus had to pass through support filters to reach the cultures, showing a diffusible nature consistent with their small size.
Cell death, as shown by ''false yellow staining'' (Fig. 2 A) , was almost completely confined to the stratum pyramidale (CA3-CA4) and stratum granulosum (DG), suggesting strongly that principal neurons of the hippocampus (pyramidal and granule cells, respectively) were targets of ADDL-induced toxicity. Loss of other cell types cannot as yet be ruled out. Neurons but not astrocytes, however, were killed in dissociated hippocampal cell cultures (37) by 24-hr ADDL exposure (data not shown), consistent with the organotypic culture results. Organotypic cultures treated with conventional aggregated preparations of 20 M A␤ had control-level cell death (Fig. 2 B and  C) , as expected from the nondiffusible nature of fibrils. Cell death in slices typically was less than 5% in controls with unsupplemented medium (Fig. 2D ) or with clusterin (data not shown).
ADDLs Are Toxic at Nanomolar Doses. ADDLs were diluted logarithmically to estimate their potency in evoking cell death (Fig. 2D) . Fig 2D Inset illustrates null and maximal cell death responses. Image analysis was used to quantify dead cell and live cell staining in fields containing the DG͞CA3 areas. Even after 1,000-fold dilution (5 nM A␤), ADDL-evoked cell death was Ͼ20%, greater than half the maximum. This high potency, coupled with diffusibility demonstrated above, makes ADDL toxicity especially pernicious.
ADDLs Bind to Particular Cell Surface Proteins. Toxin receptors recently have been identified for conventionally prepared fibrillar A␤ (38, 39) . Because neuronal death at low ADDL doses suggested possible involvement of signaling mechanisms, experiments were undertaken to determine if specific cell surface binding sites existed for ADDLs. Fig. 3 shows FACScan analysis of ADDL immunoreactivity in suspensions of the B103 CNS neuronal cell line (35) and of dissociated hippocampal cells. For B103 cells, addition of ADDLs caused a large increase in cell-associated fluorescence. Suspensions of hippocampal cells also bound ADDLs, but less well than B103 cells. Because hippocampal tissue was trypsinized (with only a 2-hr recovery) to obtain cells for analysis, the relatively low level of binding might be caused by toxin receptor proteolysis, although this has yet to be established. However, yeast cells, which present primarily a carbohydrate surface, showed no ADDL-dependent fluorescence. Even brief trypsinization of B103 cell surfaces inhibited subsequent ADDL binding by more than 90% (Fig. 3) . ADDL binding sites thus are found in the particular molecular moieties removed from the membrane by trypsin. Consistent with removal of binding sites by trypsin, it was found that cell-surface tryptic peptides released into the culture medium (0.25 mg͞ml) inhibited ADDL binding by Ͼ90% (Fig. 3 Right). Controls exposed to BSA, even at 100 mg͞ml, had no loss of binding. Tryptic peptides, if added after ADDLs were already attached to cells, did not lower fluorescence intensities; the peptides thus did not compromise quantitation of bound ADDLs. Besides blocking ADDL binding, the tryptic peptides also inhibited ADDL-evoked cell death ( Fig. 3 ; 75% reduction in cell death, P Ͻ 0.002). Overall, the data show that ADDL binding sites comprise particular domains of cell surface proteins and that these domains, when solubilized by trypsin, provide neuroprotective, ADDLneutralizing activity.
Fyn Kinase Knockout Protects Against ADDL Neurotoxicity. The impact of ADDLs on brain slices was compared in isogenic fyn Ϫ/Ϫ and fyn ϩ/ϩ animals. Fyn is up-regulated in AD-afflicted neurons (29) and belongs to the Src-family of protein tyrosine kinases, which are central to multiple cellular signals and responses (40) . Fyn may be activated by conventional A␤ (41) , and Fyn knockout mice have reduced apoptosis in developing hippocampus (42) .
In hippocampal slices from Fyn knockout animals, ADDLevoked cell death did not occur (Fig. 4 Upper Right). The amount of death in these slices was indistinguishable from controls ( Fig. 4 Lower). Quantitatively, cell death with ADDLs present was five times greater in Fyn wild-type than in Fyn knockout slices. Analysis (ANOVA) with the Tukey multiple comparison gave a value of P Ͻ 0.001 for the ADDL Fyn wild-type data compared with all other conditions. Although loss of Fyn kinase clearly protected DG and CA3 hippocampal regions from cell death induced by ADDLs, the neuroprotective effect was selective; hippocampal cell death evoked by N-methyl-D-aspartate (NMDA) receptor agonists (43, 44) was unaffected (data not shown). Results establish that the mechanism through which ADDLs exerted their toxicity is blocked by knockout of Fyn protein tyrosine kinase.
ADDLs Disrupt LTP. LTP is a classic paradigm for synaptic plasticity and a model for memory and learning, faculties that are selectively lost in early stage AD. Because of the importance of Fyn to LTP (42) , experiments were done to examine the effects of ADDLs (made in the cold) on medial perforant path-granule cell LTP. In hippocampal slices from young adult rats, inhibition of LTP by ADDLs was clearly evident (Fig. 5) . Hippocampal slices (n ϭ 6) exposed to 500 nM ADDLs for 45 min prior showed no potentiation in the population spike 30 min after the tetanic stimulation (mean amplitude, 99 Ϯ 7.6%). In contrast, LTP was readily induced in slices incubated with vehicle (n ϭ 6), with an amplitude of 138 Ϯ 8.1% for the last 10 min; this value is comparable to that previously demonstrated in this age group (36) . Although LTP was absent in ADDL-treated slices, their cells were competent to generate action potentials and showed no signs of degeneration. Thus, in less than an hour, ADDLs disrupted LTP.
DISCUSSION
Experiments presented here characterize A␤ oligomers that are soluble and highly neurotoxic. These small oligomers (ADDLs) assemble under conditions that block fibril formation, and they kill hippocampal neurons at nanomolar concentrations. Although the basis for their potent toxicity is not known, ADDLs bind to cell surfaces at trypsin-sensitive domains, and tryptic peptides obtained from cell surfaces block ADDL binding and toxicity. ADDL-evoked cell death, moreover, is eliminated by germ-line knockout of Fyn, a protein tyrosine kinase elevated in AD-afflicted neurons (29) and linked to mechanisms of apoptosis (42) and LTP (42) . Further association with hippocampal signal transduction was seen in a rapid inhibition of LTP, which occurred without lag. Loss of LTP was too fast to be explained by cell death and occurred despite continued capacity of hippocampal neurons for action potentials. We propose that in AD, early memory loss and subsequent catastrophic dementia could be caused by pathogenic ADDLs, which first disrupt synaptic plasticity and subsequently cause neuronal death via mechanisms that require specific binding and signal transduction molecules.
That small multimers of A␤ might be neurotoxic was first evident in the ability of slowly sedimenting, clusterin-chaperoned A␤ derivatives to compromise mitochondrial function in PC12 cells (19, 20) . The current data show these derivatives are fibril-free, comprising small soluble A␤ oligomers. Absence of fibrils was verified by AFM, electron microscopy, and electrophoresis. Because oligomers were present in nondenaturing as well as SDS͞PAGE, their small size could not be attributed to strong detergent action. The oligomers were relatively stable, and even SDS did not cause complete disassembly. ADDLs migrated at about 27 and 17 kDa in native gels, and at about 22 and 17 kDa on SDS gels, but the possibility that ADDLs move anomalously on gels makes these estimates only approximate. The larger species was more abundant in silver stained samples.
Whether ADDLs are present in normal or Alzheimer'safflicted human brain tissue is not yet known. This possibility is supported, however, by known interactions between clusterin and A␤ (28, (46) (47) (48) . Like A␤ (29) , clusterin is up-regulated in AD brain (19, 45, 49) and occurs in amyloid plaques (25) , clearly in proximity to A␤ . Fractionation experiments also have indicated the existence of water soluble oligomers of A␤ that are increased 12-fold in AD brains (50) . Soluble A␤ also is increased in brains from Down's patients (51) . ADDL-like oligomers also occur spontaneously at very low concentrations in medium conditioned by amyloid precursor protein (APP)-transfected CHO cells (52); intriguingly, mutant presenilin genes, which elevate production of A␤ and are associated with familial AD, increase the abundance of these stable A␤ oligomers (53) . As yet, the conditioned medium species have not been tested for toxicity. Reports of CNS degeneration in animals carrying a mutant APP transgene but lacking amyloid deposits (14) possibly could be explained by ADDL neurotoxicity in the transgenic animals.
Whereas our current and earlier reports (19, 20) showed that clusterin increases toxicity of A␤ 1-42 solutions, Boggs et al. (28) have found that clusterin protects against A␤ 1-40 toxicity. Although the mechanism of ADDL formation is not yet understood, this discrepancy can be explained by hypothesizing that clusterin retards the formation of fibrils from both A␤ 1-40 and A␤ solutions. When fibril formation is slowed in A␤ solutions, however, semistable oligomers (ADDLs) still form, driven presumably by the more hydrophobic Cterminus. A␤ 1-40 also can form oligomers, but these are not stable unless crosslinked (54) . Thus, retardation of fibril formation by clusterin causes opposite effects on toxicity, depending on the stability of the A␤ oligomeric species. Differential reduction in the rate of fibril formation relative to oligomerization may also play a role in the abilities of cold temperature or low A␤ concentrations to induce ADDLs.
The size and solubility of ADDLs are consistent with their selective ligand-like properties. As demonstrated by trypsininduced loss of binding sites, ADDLs bind only to particular domains of cell surface proteins. Patchy distribution of ADDL binding sites observed by immunofluorescence microscopy (M.P.L., A.K.B., C.E.F., G.A., and W.L.K., unpublished data) and the absence of ADDL binding to yeast cells (Fig. 3) (Fig. 3) .
The sequence of events downstream from ADDL binding is not known. However, ADDL toxicity was found to depend on expression of Fyn, a protein tyrosine kinase of the Src family. Slices from Fyn knockout animals were completely protected against ADDL toxicity (Fig. 4) . The dependence of ADDLevoked cell death on Fyn is especially intriguing because of elevated Fyn immunoreactivity reported for PHF-1 positive neurons in AD-afflicted brain tissue (28) . Src family kinases are germane to multiple transduction pathways (40, 56) , and Fyn knockout animals previously were found to exhibit reduced neuronal apoptosis in the developing hippocampus (42) . Although the basis for neuroprotection by Fyn knockout is unknown, the effect is selective, as NMDA agonists remain highly potent neurotoxins in Fyn knockout animals (data not shown). Because NMDA receptor antagonists also did not inhibit ADDL toxicity (M.P.L. et al., unpublished data), it is likely that ADDL-evoked cell death is not mediated indirectly by NMDA receptors. Theoretically, Fyn could be a downstream effector of either Ca 2ϩ or reactive oxygen species (ROS), which have been implicated in cell death caused by conventional A␤ preparations (57) (58) (59) . Previous studies in nonneuronal cells have shown that both Ca 2ϩ and ROS are relevant to signaling via Src family protein tyrosine kinases (59) (60) (61) . In neuronal cells, toxicity of traditional A␤ preparations also has been linked to transduction molecules associated with focal contact signaling (32, 62, 63) , a cascade that includes Fyn (41) . In B103 cells, ADDLs have been found to stimulate Fyn kinase Ϸ2-fold within 30 min (C.Z. and W.L.K., unpublished data). Ectopic stimulation of Fyn activity, which can be mitogenic (64) , potentially could lead to nerve cell death via mitotic catastrophe. The idea that unbalanced mitogenic signaling can trigger cell death has had increasing support, including data from neuronal systems (65) . The recent finding that AD brain has ectopically expressed cell cycle proteins (67) indicates that this hypothesis is potentially viable for AD.
In addition to evoking Fyn-dependent nerve cell death, ADDLs also inhibit LTP, a classic model for synaptic plasticity. Of particular significance, this inhibition is extremely rapid; after only 45 min, ADDLs completely block LTP in brain slices (Fig. 5) . Preliminary experiments also show this rapid effect by using LTP assays in vivo (M.P.L. et al., unpublished data). Conceivably, the ADDL effect could be related to disruption of Fyn signaling. In Fyn knockout mice, LTP is abnormal (42) , but in animals with Fyn restored postnatally, LTP is improved, indicating the electrophysiological effect of Fyn knockout is not developmental (66) . The inhibition of LTP by ADDLs is not caused by cell death, because at 45 min there are no signs of overt cytodegeneration; moreover, cells are electrophysiologically active, albeit lacking in LTP. ADDLs thus have profound neurological effects well in advance of tissue damage. If A␤ derivatives such as ADDLs prove to be part of Alzheimer's pathogenesis, these results suggest that it would be theoretically feasible to halt or reverse the disease during its early stages. The particular cell surface proteins and signal transduction molecules that mediate ADDL toxicity would be important targets for drug-based therapeutic approaches.
